<DOC>
	<DOCNO>NCT00521534</DOCNO>
	<brief_summary>Background Introduction : SDB increasingly recognize co-morbidity significant impact overall health . The disorder implicate development hypertension , atherosclerotic cardiovascular disease well arrhythmia , stroke progression congestive heart failure . The disorder prevalent among male , estimate affect upto 24 % general population . Its prevalence increase age , particularly prevalent among patient congestive heart failure prevalence rise 51 % group . Interestingly , recent evidence point potential impact treat sleep disorder breathing , heart failure patient . At time , recent report beneficial impact atrial overdrive pacing SDB , stir interest potentially effective well tolerate non-pharmacologic mean therapy disorder . Particularly time cardiac resynchronization therapy utilize biventricular pacing demonstrate significant impact heart failure , interplay CHF SDB pacemaker base therapy begs exploration . The interdependence potential positive impact entity need elucidate research refinement therapeutic tool . Furthermore , study aim explore potential neurohormonal influence affection disorder . Specific Aims Hypotheses : Specific Aim # 1 : To assess effect cardiac resynchronization therapy ( CRT ) without atrial pace SDB patient advance CHF 8 16 week implementation therapy . Hypothesis # 1 : Resynchronization therapy improve SDB , effect may anticipate lag improvement heart failure . Atrial pace beneficial effect addition CRT . Specific Aim # 2 : To explore effect CRT cardiac neuro-hormonal activity relation effect CHF SDB . Hypothesis # 2 : CRT neuro-hormonal modulation common path effect SDB CHF . Specific Aim # 3 : To assess prevalence sleep disorder breathing ( SDB ) patient advance congestive heart failure ( CHF ) . Hypothesis # 3 : SDB prevalent yet recognize patient population . Research Design : This observational study build double blind prospective randomize interventional substudy potential confounder i.e . atrial pacing . All patient receive CRT defibrillator clinical indication ( CRT-D ) . Investigators EP physician well patient blind pace mode . After screen run period back pace baseline polysomnogram ( PSG ) perform . Patients randomize atrial overdrive atrial track pace mode six month , patient receive CRT . Sleep study perform baseline three month interval . Subjects : Patients refer implantation CRT -D recruit trial . Patients include indicated device clinical ground . Outcome Measures : 1.Sleep quality relate Parameters : The following collect time PSG : MAP-PSQI , PSG parameter sleep quality architecture , apnea hypopnea index , oxygen saturation well biochemical marker sleep efficiency . 2.Heart Failure Parameters : The following obtain time PSG : Minnesota Living Heart Failure Questionnaire , Clinical echocardiographic measure heart failure progression biochemical marker heart failure severity . Power Analysis : An improvement SDB initial randomization arm assume , however assume atrial overdrive arm offer improvement atrial track arm equal magnitude . An arbitrary estimate would twenty percent improvement atrial overdrive arm . The corresponding estimate 40 % improvement due CRT . To achieve 0.80 power thirty four data set need collect .</brief_summary>
	<brief_title>Impact Resynchronization Therapy Sleep Disordered Breathing Advanced Congestive Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Respiratory Aspiration</mesh_term>
	<criteria>Age &gt; 18years Indication CRT device implant : Congestive heart failure ( NYHA Class III IV ) Ejection fraction le 36 % Evidence intraventricular dyssynchrony ( QRS duration &gt; 120ms positive tissue doppler echocardiogram ) . Have life expectancy least 6 month Are optimal pharmaceutical therapy ( OPT ) Ability willingness sign inform consent Unstable angina , Canadian Cardiac Society Class III great . Patients unstable heart failure define need intravenous inotropes inability achieve stable medical regimen 48 hour . Deterioration CHF time study require hospital admission follow : A significant change pharmaceutical regimen ( see : Pharmacologic Therapy ) A change pace mode parameter ( exception mode inadvertently program incorrectly implant ) A need inotrope support A downward change functional class one grade discharge Women childbearing age pregnant refuse pregnancy test reliable contraception mean duration study . Not successful percutaneous CRT device implant . Chronic atrial fibrillation . Patients currently know sleep apnea treat CPAP . ( Patients prescribe CPAP compliant one month great eligible enrollment . ) AHI &gt; 50 PSG portable sleep study . Mean nocturnal heart rate &gt; 80 bpm baseline PSG exclude randomization . Patients receive , narcotic benzodiazepine unless stable dos . Current alcohol narcotic abuse document patient medical record . Inability unwillingness sign inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Sleep relate Breathing Disorder</keyword>
	<keyword>Congestive Heart Failure</keyword>
	<keyword>Atrial Overdrive Pacing</keyword>
	<keyword>Cardiac Resynchronization Therapy</keyword>
</DOC>